XPO1/CRM1 inhibition causes antitumor effects by mitochondrial accumulation of eIF5A

Takahito Miyake, Sunila Pradeep, Sherry Y. Wu, Rajesha Rupaimoole, Behrouz Zand, Yunfei Wen, Kshipra M. Gharpure, Archana S. Nagaraja, Wei Hu, Min Soon Cho, Heather J. Dalton, Rebecca A. Previs, Morgan L. Taylor, Takeshi Hisamatsu, Yu Kang, Tao Liu, Sharon Shacham, Dilara McCauley, David H. Hawke, John E. WiktorowiczRobert L. Coleman, Anil K. Sood

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'XPO1/CRM1 inhibition causes antitumor effects by mitochondrial accumulation of eIF5A'. Together they form a unique fingerprint.

INIS

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science